Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Genetically engineered polymers for drug delivery.

A Nagarsekar1, H Ghandehari

  • 1Department of Pharmaceutics and the National Center for the Development of Natural Products, The University of Mississippi, 38677, USA.

Journal of Drug Targeting
|December 30, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Contemporary Sterilization Protocols of Healing Abutments for Reusability: A Systematic Review.

JDR clinical and translational research·2021
Same author

Silk-elastinlike copolymers enhance bioaccumulation of semisynthetic glycosaminoglycan ethers for prevention of radiation induced proctitis.

Journal of controlled release : official journal of the Controlled Release Society·2021
Same author

A Phase 2b randomized trial of lorecivivint, a novel intra-articular CLK2/DYRK1A inhibitor and Wnt pathway modulator for knee osteoarthritis.

Osteoarthritis and cartilage·2021
Same author

Advanced drug delivery 2020 - Parts 1,2 and 3.

Advanced drug delivery reviews·2020
Same author

Efficacy and safety of a recombinant factor IX (Bax326) in previously treated patients with severe or moderately severe haemophilia B undergoing surgical or other invasive procedures: a prospective, open-label, uncontrolled, multicentre, phase III study.

Haemophilia : the official journal of the World Federation of Hemophilia·2014
Same author

Poly(amido amine) dendrimers as absorption enhancers for oral delivery of camptothecin.

International journal of pharmaceutics·2013
Same journal

Galactosylated chitosan-functionalized liposome for targeted delivery of <i>Coreopsis tinctoria</i> flavonoids: Protective effect in acute liver injury.

Journal of drug targeting·2026
Same journal

Tubulin as a well-established yet underexploited target: new opportunities for drugs repurposing?

Journal of drug targeting·2026
Same journal

Physcion-loaded, folic acid-conjugated DSPE-PEG liposomes for targeted therapy of ulcerative colitis.

Journal of drug targeting·2026
Same journal

Enzyme-responsive 2-dimensional nanomaterials for targeted breast cancer treatment.

Journal of drug targeting·2026
Same journal

Integrating antibody-drug conjugates, multispecific antibodies, targeted protein degradation and nanomedicine in precision oncology.

Journal of drug targeting·2026
Same journal

Nanomaterials for subcellular organelle targeting: unlocking new avenues for enhanced therapeutic effectiveness.

Journal of drug targeting·2026
See all related articles

Genetic engineering enables precise synthesis of protein-based polymers for advanced drug delivery. These engineered polymers offer superior control over structure, leading to improved drug release and pharmacokinetic profiles compared to traditional methods.

Area of Science:

  • Biomaterials Science
  • Polymer Chemistry
  • Genetic Engineering

Background:

  • Traditional chemical polymerization yields polymers with heterogeneous molecular weights and statistical monomer compositions.
  • The molecular structure of polymeric carriers significantly impacts their biological fate and drug release kinetics.
  • Existing synthetic polymers present limitations in achieving precise control over drug delivery characteristics.

Purpose of the Study:

  • To review the rationale and methodology for synthesizing protein-based polymers using genetic engineering.
  • To discuss the current applications of these engineered polymers in drug delivery systems.
  • To explore the future potential of genetically engineered polymers for novel therapeutic developments.

Main Methods:

Related Experiment Videos

  • Utilizing recombinant DNA technology to synthesize protein-based polymers.
  • Designing polymers with well-defined monomer composition, sequence, and stereochemistry.
  • Leveraging genetic engineering for precise control over polymer architecture and molecular weight distribution.

    • Main Results:

    • Genetically engineered polymers exhibit superior control over structure compared to chemically synthesized polymers.
    • These polymers demonstrate potential for enhanced biorecognition, pharmacokinetics, and biodegradation.
    • Precisely structured polymers facilitate predictable and tunable drug release profiles.

    Conclusions:

    • Genetic engineering offers a powerful platform for creating advanced polymeric drug carriers.
    • These engineered materials hold significant promise for developing next-generation drug delivery systems with tailored properties.
    • Further research into genetically engineered polymers can unlock new therapeutic possibilities.